Nanodrug Delivery Systems for Acute Lymphoblastic Leukemia Therapy

Nanodrug Delivery Systems for Acute Lymphoblastic Leukemia Therapy

Acute lymphoblastic leukemia (ALL) is a malignant tumor caused by abnormal proliferation of B-line or T-line lymphocytes in the bone marrow. Traditional treatments have limitations. Because of their unique advantages, nanodrug delivery systems (NDDSs) show great potential in the treatment of ALL. In...

Full description

Saved in:
Bibliographic Details
Main Authors: Aiyun Yang, Yuanfang Lu, Zuo Zhang, Jianhua Wang
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmaceuticals
Subjects:
acute lymphoblastic leukemia
drug delivery
therapy
nanovehicles
Online Access:https://www.mdpi.com/1424-8247/18/5/639
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items